Menu Search
Equities

Syndax Pharmaceuticals Inc

1T3:STU

Syndax Pharmaceuticals Inc

Actions
  • Price (EUR)15.90
  • Today's Change-4.50 / -22.06%
  • Shares traded700.00
  • 1 Year change+17.78%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Syndax Pharmaceuticals Inc's net income fell 40.19% from a loss of 149.34m to a larger loss of 209.36m despite flat revenues.
Gross margin--
Net profit margin-1,856.64%
Operating margin-2,007.58%
Return on assets-72.01%
Return on equity-81.88%
Return on investment-81.78%
More ▼

Cash flow in USDView more

In 2023, Syndax Pharmaceuticals Inc increased its cash reserves by 296.95%, or 221.14m. Cash Flow from Financing totalled 264.13m or -- of revenues. In addition the company used 160.60m for operations while cash from investing totalled 117.61m.
Cash flow per share-3.62
Price/Cash flow per share--
Book value per share4.28
Tangible book value per share4.28
More ▼

Balance sheet in USDView more

Syndax Pharmaceuticals Inc has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 295.39m.
Current ratio6.99
Quick ratio--
Total debt/total equity0.00003
Total debt/total capital0.00003
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.